GLP-1tirzepatidetype 2 diabetesannals of internal medicine

Annals On Call episode weighs tirzepatide against intensified conventional diabetes care

The Annals of Internal Medicine podcast, with Centor and Batch, discusses how tirzepatide compares with intensified usual care in poorly controlled type 2 diabetes.

By Maren Holt · Senior Reporter, GLP-1

Oct 5 20:00 ETSource: Annals of internal medicine

The wire

01Annals of Internal Medicine published an Annals On Call discussion of tirzepatide versus intensified conventional care for poorly controlled type 2 diabetes.
02Prescribers deciding between adding an incretin and intensifying existing regimens are the intended audience for the discussion.
03The episode is commentary on published work rather than new trial data; clinicians should go to the underlying study for endpoints and effect sizes.

From the source

Annals On Call - Tirzepatide Versus Intensified Conventional Care for Poorly Controlled Type 2 Diabetes
Annals of internal medicine · 2026 Oct 6 · Centor RM, Batch BC et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/42832795/